Drugs / reproterol
last change Oct 2008 re-read 2 minutes ago

reproterol

Small molecule targets ADRB2 via activation

Developed for
asthma
Investigated by
ClinResearch, GmbH · MEDA Pharma GmbH & Co. KG · Sanofi

Trials 1 · a red edge is where a trial was stopped

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00777348 Nov 2007 → Oct 2008 asthma MEDA Pharma GmbH & Co. KG Completed No outcome recorded

Evidence & citations 12 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as reproterol ClinicalTrials.gov intervention name — accepted as the source's own label NCT00777348
Known as Asmaterolo ChEMBL registry synonym — accepted as the source's own label CHEMBL1095607
Known as Bronchodil ChEMBL registry synonym — accepted as the source's own label CHEMBL1095607
Known as Bronchospasmin ChEMBL registry synonym — accepted as the source's own label CHEMBL1095607
Known as D-1959 ChEMBL registry synonym — accepted as the source's own label CHEMBL1095607
Known as D-1959 HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL1095607
Known as D-1959.HCL ChEMBL registry synonym — accepted as the source's own label CHEMBL1095607
Known as REPROTEROL HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL1095607
Known as W-2946M ChEMBL registry synonym — accepted as the source's own label CHEMBL1095607
Action Activate “Beta-2 adrenergic receptor agonist” CHEMBL1095607
Modality Small molecule CHEMBL1095607
Target ADRB2 “Beta-2 adrenergic receptor agonist” CHEMBL1095607